Track the 제일약품 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제일약품 has logged 1 insider filings. Market capitalisation: €140.9bn. The latest transaction was filed on 30 April 2026 (Sale). Among the most active insiders: 한승수. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
제일약품 是一家韩国公司,专注于医疗保健和制药领域。该公司在 XKRX 证券交易所上市。